8-K//Current report
Ultragenyx Pharmaceutical Inc. 8-K
Accession 0000950170-20-000059
$RARECIK 0001515673operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 8:07 PM ET
Size
1.0 MB
Accession
0000950170-20-000059
Documents
- 8-Krare-2020-07-30-8-k_er.htmPrimary
8-K
- EX-99.1rare-ex99_1.htm
EX-99.1
- GRAPHICimg_0.jpg
GRAPHIC
- EX-101.SCHrare-20200730.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABrare-20200730_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErare-20200730_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLrare-2020-07-30-8-k_er_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-20-000059-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 8:07 PM ET
- Size
- 1.0 MB